Pre\u00adci\u00adPoint Group GmbH has suc\u00adcess\u00adfully closed its Series A financ\u00ading round of EUR 10 mil\u00adlion. Exist\u00ading investors, includ\u00ading bm\u2011t beteili\u00adgungs\u00adman\u00adage\u00adment th\u00fcrin\u00adgen gmbh (bm|t), and a new fam\u00adily office invested in the Ger\u00adman MedTech startup. This financ\u00ading round will advance the inter\u00adna\u00adtional com\u00admer\u00adcial\u00adiza\u00adtion of the company\u00b4s first IVD med\u00adical prod\u00aduct, mar\u00adket entry in the USA as well as fur\u00adther tech\u00adno\u00adlog\u00adi\u00adcal devel\u00adop\u00adment of addi\u00adtional inno\u00adv\u00ada\u00adtive solutions.<\/p>\n
In 2022, Pre\u00adci\u00adPoint will com\u00admer\u00adcially launch the iO:M8 ROSE, a glob\u00adally unique solu\u00adtion for the dig\u00adi\u00adti\u00adza\u00adtion of intra\u00adop\u00ader\u00ada\u00adtive micro\u00adscopic assess\u00adments dur\u00ading can\u00adcer surg\u00aderies. These exam\u00adi\u00adna\u00adtions, dur\u00ading which pathol\u00ado\u00adgists deter\u00admine whether suf\u00adfi\u00adcient mate\u00adr\u00adial has been removed from the patient\u2019s body and whether the mar\u00adgins are free of can\u00adcer cells, are tra\u00addi\u00adtion\u00adally per\u00adformed by spe\u00adcial\u00adists being bound to loca\u00adtion and time using clas\u00adsic light micro\u00adscopes for imag\u00ading. PreciPoint\u2019s solu\u00adtions enable entirely new ways of work\u00ading, allow\u00ading sig\u00adnif\u00adi\u00adcant cost sav\u00adings and, most impor\u00adtantly, bet\u00adter patient care.<\/p>\n
Pre\u00adci\u00adPoint spe\u00adcial\u00adizes in the dig\u00adi\u00adti\u00adza\u00adtion of microscopy and lab\u00ado\u00adra\u00adtory work\u00adflows. The com\u00adpany offers solu\u00adtions for appli\u00adca\u00adtions in med\u00adi\u00adcine, research, and edu\u00adca\u00adtion and its devices are used in many lab\u00ado\u00adra\u00adto\u00adries world\u00adwide. It is cen\u00adtral to PreciPoint\u2019s phi\u00adlos\u00ado\u00adphy to develop prod\u00aducts together with users. Thus, the com\u00adpany works with many respected pathol\u00ado\u00adgists in Ger\u00admany to design prod\u00aducts that meet the high\u00adest stan\u00addards while being quick and easy to use. This includes a focus on the devel\u00adop\u00adment of tech\u00adnolo\u00adgies for Label-Free Diag\u00adnos\u00adtics, where sam\u00adples can be viewed entirely with\u00adout expen\u00adsive and time-con\u00adsum\u00ading sam\u00adple prepa\u00adra\u00adtion, as well as the devel\u00adop\u00adment of prod\u00aduct solu\u00adtions for high-speed appli\u00adca\u00adtions to help meet the increas\u00ading demand in pathol\u00adogy labs.<\/p>\n
Excel\u00adlent prospects that also con\u00advinced the investors: \u201cSince our seed invest\u00adment in 2019, the team around the two co-founders and man\u00adag\u00ading direc\u00adtors Nico\u00adlas Weiss and Dominik Ger\u00adber has made enor\u00admous progress. Renowned dis\u00adtri\u00adb\u00adu\u00adtion part\u00adners could be acquired, new prod\u00aducts could be devel\u00adoped and suc\u00adcess\u00adfully placed on the mar\u00adket. At the same time, the pre\u00adreq\u00adui\u00adsites were cre\u00adated to quickly scale the com\u00adpany. We firmly believe that Pre\u00adci\u00adPoint, as a ISO13485 cer\u00adti\u00adfied med\u00adical device com\u00adpany, will be able to suc\u00adcess\u00adfully posi\u00adtion its prod\u00aduct port\u00adfo\u00adlio on the Euro\u00adpean and Amer\u00adi\u00adcan mar\u00adkets,\u201d said Ste\u00adfan Jahn, Senior Invest\u00adment Man\u00adager at bm|t.<\/p>\n
Pre\u00adci\u00adPoint spe\u00adcial\u00adizes in the devel\u00adop\u00adment, pro\u00adduc\u00adtion, and mar\u00adket\u00ading of inno\u00adv\u00ada\u00adtive dig\u00adi\u00adti\u00adza\u00adtion solu\u00adtions and pho\u00adton\u00adics sys\u00adtems in the field of microscopy. Already offered on the mar\u00adket are the microscopy solu\u00adtions M8, O8 as well as FRITZ. All devices are fully motor\u00adized trans\u00admit\u00adted light micro\u00adscopes users con\u00adtrol via soft\u00adware. The solu\u00adtions work dig\u00adi\u00adtally, do not require an eye\u00adpiece, and pro\u00adduce high-res\u00ado\u00adlu\u00adtion images of the sam\u00adples, which can eas\u00adily be stored dig\u00adi\u00adtally. The micro\u00adscopes impress with easy and intu\u00aditive user inter\u00adfaces. Fur\u00adther\u00admore, the devices can be equipped with a remote func\u00adtion so that they can also be accessed from any loca\u00adtion. In addi\u00adtion to hard\u00adware prod\u00aducts, the com\u00adpany offers ver\u00adsa\u00adtile soft\u00adware appli\u00adca\u00adtions with which the images can be visu\u00adal\u00adized, processed, and ana\u00adlyzed. The vir\u00adtual microscopy plat\u00adform Pre\u00adci\u00adCloud enables new work\u00ading mod\u00adels between experts, researchers, and stu\u00addents. PreciPoint\u2019s cus\u00adtomer base already includes many well-known users world\u00adwide. Based in Freis\u00ading, Ger\u00admany, Pre\u00adci\u00adPoint is an ISO 13485 cer\u00adti\u00adfied med\u00adical device com\u00adpany and one of the Top Star\u00adtups in Ger\u00admany. The com\u00adpany has won var\u00adi\u00adous awards, includ\u00ading 3rd<\/sup> place as Top Inno\u00adva\u00adtor 2022, in which Pre\u00adci\u00adPoint pre\u00advailed as a par\u00adtic\u00adu\u00adlarly inno\u00adv\u00ada\u00adtive com\u00adpany against almost 450 com\u00adpa\u00adnies, and the award as Top Startup Employer in the health\u00adcare sector.<\/p>\n